Lymphoma refers to a a group of cancers that strike the lymphatic system, which is a key part of the immune system. Lymphomas are broadly classified as either Hodgkins or non-Hodgkins. Some lymphomas are highly curable; others require complex treatment.
The Hutchinson Center pioneered bone marrow transplantation as a treatment for lymphoma, leukemia and other cancers, amd our scientists are developing promising new lymphoma therapies. Today, the Center is pursuing new treatments such as cord blood transplantation.
Learn more about the our research on the two major types of lymphoma:
Hodgkin lymphoma is marked by the presence of the Reed-Sternberg cell, a large cell that increases in number as the disease advances. Hodgkin lymphoma is highly curable with a survival rate that is considered very high.
There are several types of Non-Hodgkin lymphomas that are typically characterized as fast or slow-growing and as originating from T-cells or B-cells, both of which are types of white blood cells. Prognosis and treatment depend on the disease's stage and type.